A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

Peer review reports

Original Submission
14 Jan 2019	Submitted	Original manuscript
3 Sep 2019	Reviewed	Reviewer Report - Kirsty Loudon
27 Sep 2019	Author responded	Author comments - Judy Bradley
Resubmission - Version 2
27 Sep 2019	Submitted	Manuscript version 2
29 Sep 2019	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
29 Sep 2019	Editorially accepted
19 Dec 2019	Article published	10.1186/s13063-019-3766-9

Back to article page